Ketamine Treatment and Infusion Therapy: Understanding Your Options for Treatment-Resistant Depression

When someone has tried antidepressant after antidepressant without finding lasting relief, the experience can be profoundly demoralising. Depression already distorts how we see the future, and repeated treatment failures can reinforce a sense that nothing will ever work. But a growing body of evidence, backed by real-world clinical experience at specialist centres across New York City, suggests that ketamine treatment offers something genuinely different for patients who have reached that point.

This article explains how ketamine works as a psychiatric treatment, what the infusion process involves, and what patients in New York City should know before pursuing this form of care.

Why Ketamine Is Different From Other Antidepressants

Most antidepressant medications work through one of a few related mechanisms. Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and older classes of antidepressants like tricyclics and MAOIs all target monoamine neurotransmitters, primarily serotonin, norepinephrine, and dopamine. While these drugs help many patients, they share a common limitation: they take weeks to produce their full therapeutic effect, and a significant proportion of patients do not respond adequately even after sustained use at appropriate doses.

Ketamine operates through an entirely different biological pathway. It is primarily an NMDA receptor antagonist, meaning it blocks a specific type of glutamate receptor in the brain. Glutamate is the brain’s main excitatory neurotransmitter, and the NMDA receptor plays a central role in synaptic plasticity, the ability of neural connections to strengthen or weaken based on experience and stimulation.

In patients with depression, particularly treatment-resistant depression, glutamate signalling and synaptic function in key brain regions are often disrupted. Ketamine appears to rapidly restore some of this signalling, promoting the formation of new synaptic connections in areas like the prefrontal cortex and hippocampus. The result, for many patients, is a rapid and significant improvement in mood that can begin within hours of treatment.

This speed of action is one of ketamine’s most clinically meaningful features. For patients in acute distress, the idea that relief might come within days rather than weeks represents a qualitatively different therapeutic offer.

What Ketamine Treatment in New York City Looks Like

For patients exploring ketamine treatment in the city, Village TMS offers the kind of psychiatry-led care that responsible ketamine treatment demands. The most established form of ketamine treatment is intravenous infusion, administered in a supervised clinical setting by or under the direct supervision of a physician.

A standard induction course typically involves six infusions delivered over two to three weeks. Each infusion lasts approximately 40 to 60 minutes. During this time, patients are monitored continuously for vital signs and psychological response. The dissociative effects of ketamine, which many patients describe as a dreamlike or floating sensation, are expected and are a normal part of the treatment experience. They resolve as the ketamine clears the system, usually within one to two hours of the infusion ending.

Maintenance infusions may be recommended following the initial induction course to sustain the antidepressant response. The frequency of maintenance treatments varies by patient and is determined by the treating clinician based on how the patient responds and how long their benefit is maintained between sessions.

A well-run ketamine clinic will conduct a thorough psychiatric evaluation before beginning treatment to ensure that the patient is an appropriate candidate, establish a clear treatment plan, and document baseline symptoms so that progress can be measured objectively throughout the course.

Ketamine Infusion Therapy: What the Research Says

The evidence base for ketamine infusion as a treatment for depression is now substantial. Multiple randomised controlled trials, meta-analyses, and large observational studies have confirmed that intravenous ketamine produces rapid and significant antidepressant effects in patients with treatment-resistant depression.

Research published by the National Institutes of Health has demonstrated that ketamine infusion produces rapid reductions in depressive symptoms in patients who have failed multiple prior treatments. Response rates in clinical settings are meaningful, with many studies reporting that 50 to 70 percent of patients experience significant improvement following a standard induction course.

The durability of the response is a more complex picture. Some patients maintain their improvement for months after a course of infusions. Others find that benefits fade after several weeks, requiring maintenance infusions to sustain the effect. Research into optimal maintenance protocols is ongoing, and clinicians at specialist centres are increasingly able to personalise maintenance schedules based on individual patient response.

For patients seeking Ketamine Infusion NYC, choosing a provider with strong clinical oversight and a clear approach to both the induction and maintenance phases is essential for maximising the chances of durable benefit.

The Safety Profile of Ketamine Treatment

Ketamine is a powerful medication with a well-characterised safety profile when used in supervised clinical settings. The most common short-term effects during and immediately after infusion include dissociative experiences, mild increases in blood pressure and heart rate, and occasionally nausea. These effects are transient and resolve as the drug clears the system.

Patients with certain medical conditions, including uncontrolled hypertension, active psychosis, a history of substance use disorder, or specific cardiovascular conditions, may not be appropriate candidates for ketamine treatment. This is one of the reasons why a thorough pre-treatment medical and psychiatric evaluation is not optional but essential.

Longer-term safety considerations, particularly around repeated use, are an area of active research. The doses used in clinical ketamine treatment are substantially lower than those associated with recreational misuse, and the controlled, supervised nature of clinical administration is fundamentally different from unsupervised use. Responsible providers monitor patients throughout their treatment course and adjust protocols if any concerns arise.

Integrating Ketamine With a Broader Treatment Plan

Ketamine treatment is most effective when it is delivered as part of a comprehensive mental health care plan rather than as a standalone intervention. The rapid mood improvement that ketamine can produce creates a window of neuroplasticity during which patients may be particularly receptive to psychotherapy and other forms of mental health work.

Many specialist clinics recommend that patients engage in therapy, whether cognitive behavioural, psychodynamic, or another evidence-based modality, alongside or following ketamine treatment. Some clinicians also incorporate ketamine-assisted psychotherapy, which involves conducting structured therapeutic work during or immediately after the ketamine session while the patient is in a heightened state of psychological openness.

At Village TMS in New York City, the clinical team takes a holistic approach to psychiatric care, recognising that ketamine treatment is most powerful when embedded in a broader, personalised plan. Their psychiatrists work closely with patients to understand their full clinical history and design a treatment programme that addresses their needs comprehensively.

Taking the Next Step

If you are living with treatment-resistant depression and have begun to wonder whether there is anything left to try, ketamine treatment in New York City is worth exploring seriously. The evidence is compelling, the access to quality providers in the city is real, and the potential for rapid relief after years of inadequate response represents something genuinely worth pursuing.

Village TMS offers comprehensive psychiatric evaluations and personalised ketamine treatment programmes for patients across New York City. Their experienced team will work with you to determine whether ketamine is the right option for your situation and, if so, deliver it with the rigour and care that this treatment demands. Reach out to Village TMS today to schedule your consultation and begin exploring what is possible.